| tweede vaccinatie tegen 'Severe acute respiratory syndrome'-coronavirus 2 met niet-replicerende recombinante virale vector coderend voor 'spike'-eiwit (verrichting) |
| tweede vaccinatie tegen SARS-CoV-2 met niet-replicerende recombinante virale vector coderend voor S-eiwit |
| tweede vaccinatie tegen 'Severe acute respiratory syndrome'-coronavirus 2 met niet-replicerende recombinante virale vector coderend voor 'spike'-eiwit
tweede actieve immunisatie met recombinante niet-replicerende virale vector coderend voor 'spike'-eiwit van SARS-CoV-2
toediening van tweede vaccindosis tegen COVID-19 met niet-replicerende recombinante virale vector coderend voor S-eiwit
|
| Administration of second dose SARS-CoV-2 non-replicating viral vector vaccine |
| Second COVID-19 non-replicating viral vector immunization
Second SARS-CoV-2 non-replicating viral vector immunization
Second 2019 novel coronavirus non-replicating viral vector immunization
Second 2019-nCoV non-replicating viral vector vaccination
Administration of second dose vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein
Second severe acute respiratory syndrome coronavirus 2 non-replicating viral vector vaccination
Second COVID-19 non-replicating viral vector vaccination
Second 2019 novel coronavirus non-replicating viral vector vaccination
Second 2019-nCoV non-replicating viral vector immunization
Second SARS-CoV-2 non-replicating viral vector vaccination
|
